- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 463168, 4 pages
Highly Ordered Architecture of MicroRNA Cluster
1Department of Geriatric Cardiology, Beijing Military General Hospital, Beijing 100700, China
2The 14th Beijing High School, Beijing, 100020, China
3School of Computer Science and Engineering, Hebei University of Technology, Tianjin 300401, China
Received 18 July 2013; Accepted 3 September 2013
Academic Editor: Qinghua Cui
Copyright © 2013 Bing Shi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Although it is known that the placement of genes in a cluster may be critical for proper expression patterns, it remains largely unclear whether the orders of members in an miRNA cluster have biological insights. By investigating the relationship between expression and orders for miRNAs from the oncogenic miR-17-92 cluster, we observed a highly ordered architecture in this cluster. A significant correlation between miRNA expression level and its placement was revealed. More importantly, the placement of these miRNAs is associated with their dysregulation in cancer. Here, we presented the opinion that miRNA clusters are not arranged randomly but show highly ordered architectures, which may have critical roles in physiology and pathology.
Genes are not randomly located in the genome. It is well known that many genes are organized as gene clusters in the genome, and the placement of the gene members in a cluster may have critical roles in biological insights. A typical example is the famous Hox gene family. The relative location of the gene members in the Hox gene cluster corresponds to an expression pattern along the cephalocaudal axis, which is critical for the proper placement of segment structures of animals during early embryonic development . Furthermore, displacement of Hox members would cause abnormal development.
MicroRNAs (miRNAs) are one class of noncoding RNA genes, which mainly negatively regulate the expression of genes at the posttranscriptional level . Like protein-coding genes, a number of miRNAs are grouped into clusters in the genomes . Increasing evidence has shown that members in an miRNA cluster tend to be coexpressed and play as a whole in various physiological and pathological processes [3–5]. A typical case is the human miR-17-92 cluster, which encodes six miRNA genes (from the start to the end: hsa-mir-17, and hsa-mir-18a, hsa-mir-19a, hsa-mir-20a, hsa-mir-19b-1, hsa-mir-92a-1). This miRNA cluster has been confirmed by a number of researchers to play critical roles in various cancers, such as lung cancer , chronic lymphocytic leukaemia , retinoblastoma , breast cancer, gastrointestinal cancer , multiple myeloma , renal cell carcinoma , B-cell lymphomas , medulloblastomas [13, 14], acute lymphoblastic leukemia , thyroid cancer , and mantle cell lymphoma . Because of its strong oncogenic activity, the miR-17-92 cluster was also named as oncomiR-1. Thus, here we asked whether the placement of miRNAs in an miRNA cluster contributes to determining the miRNA expression patterns by investigating the relationship between expression and placement of miRNAs in the miR-17-92 cluster.
2. Materials and Methods
2.1. Data of miRNA Expression
We obtained the miRNA expression profile in normal tissues from the study by Liang et al. , obtained the miRNA expression profile of normal ovary and ovarian cancer from the study by Bell et al. , and obtained the miRNA expression profile of normal blood and blood of cancer patients from the study by Keller et al. .
2.2. Statistical Analysis
Statistical computations were performed using , a statistical computing language (http://www.r-project.org/), and the correlations were calculated using Spearman’s correlation, a nonparametric method.
3. Results and Discussion
3.1. The Placement of miRNA Cluster Members Shows Correlations with Their Expression Level
We analyzed the relationship between the placement of miRNA-17-92 cluster members and their expression levels using several public datasets. Each of the miRNA genes in this cluster contains two mature miRNAs being denoted as mature and mature star, respectively, that is, miR-17-5p and miR-17-3p (miR-17*). We first calculated the correlation between the miRNA placement and their expression level for the mature miRNAs in normal tissues from Liang et al.’s study . The correlation analysis revealed a significantly positive correlation between the miRNA placement and their expression level (Figure 1(a), , ) for the mature miRNAs. We confirmed this correlation using other two independent datasets, miRNA expression profile in normal ovary (, )  and miRNA expression profile in normal blood (, ) . For the mature star miRNA, because Liang’s datasets did not present expression data, we performed correlation analysis based on the other two datasets, as described previously. Interestingly, a reverse pattern was found for the mature star miRNA. The miRNA placement and their expression level show negative correlation (Figure 1(b), and ) in blood sample dataset and in the ovary sample dataset ( and ).
3.2. miRNA Placement in miRNA Clusters Plays Roles in Cancer
We further asked whether the placement of miRNAs in a cluster has roles in pathology. To address this question, we compared the expression level of the six members (both mature miRNAs and mature star miRNAs) of miR-17-92 cluster in ovary cancer samples with that in normal ovary samples. As a result, the significance ( value) shows a positive correlation (Figure 1(c), , ) with the placement for the mature miRNAs, whereas the significance shows a negative correlation (Figure 1(d), , ) with the placement for the mature star miRNAs. Furthermore, only the starting four mature miRNAs are significantly upregulated in ovary cancer samples (-test, ); whereas for mature star miRNAs, only the ending three are significantly upregulated in ovary cancer samples (-test, ). These results provide evidence that the placement of miRNA members of an miRNA cluster is correlated with the dysregulation of these miRNAs in cancer, suggesting that the placement of miRNA members of a cluster may have roles in pathological processes.
In summary, we found that the placement of miRNA members of an miRNA cluster has roles in determining the expression patterns of these miRNAs in both physiological and pathological processes. Furthermore, the mature miRNA and miRNA star miRNAs show different patterns. These results suggest that different members should have different biological functions and roles. Indeed, different researchers have obtained different observations. Using the Eμ-myc model of mouse B-cell lymphoma, Olive et al. investigated the tumorigenic potential of the six members of the miR-17-92 cluster. As a result, they found that miR-19 is the key oncogenic components of the cluster . Interestingly, however, in another research, Tsuchida et al. found that miR-92 is the key oncogenic component of the miR-17-92 cluster in colon cancer . Although different members are identified as key oncogenic component of the miR-17-92 cluster by different researchers, the difference could be interpreted using the above observations (Figures 1(c) and 1(d)). In a recent study, Chaulk et al. revealed that the pri-miRNA of miR-17-92 cluster shows a globular tertiary structure. They found that miR-92 is internalized within the core of the folded structure, which leads to a less efficiency in miR-92 biogenesis . This finding is interesting and can interpret the reason why miR-92a* (miR-92a-5p) is in a low expression level in normal tissue and is upregulated in cancer but cannot interpret the reason why miR-92a is in high expression level in normal tissue and does not show upregulation in cancer. Finally, although a correlation between the placement of miRNA members in a cluster and their expression patterns in normal and cancer samples was revealed, the reason and role of this correlation in physiological and pathological processes still remain to be answered.
Bing Shi and Mingxuan Zhu have contributed equally to this work.
This work was supported by the Natural Science Foundation of China (Grant no. 30900829).
- S. B. Carroll, “Homeotic genes and the evolution of arthropods and chordates,” Nature, vol. 376, no. 6540, pp. 479–485, 1995.
- D. P. Bartel, “MicroRNAs: genomics, biogenesis, mechanism, and function,” Cell, vol. 116, no. 2, pp. 281–297, 2004.
- M. Sawera, J. Gorodkin, S. Cirera, and M. Fredholm, “Mapping and expression studies of the mir17-92 cluster on pig Chromosome 11,” Mammalian Genome, vol. 16, no. 8, pp. 594–598, 2005.
- M. Lu, Q. Zhang, M. Deng et al., “An analysis of human microRNA and disease associations,” PLoS ONE, vol. 3, no. 10, Article ID e3420, 2008.
- D. Wang, J. Wang, M. Lu, F. Song, and Q. Cui, “Inferring the human microRNA functional similarity and functional network based on microRNA-associated diseases,” Bioinformatics, vol. 26, no. 13, pp. 1644–1650, 2010.
- Y. Hayashita, H. Osada, Y. Tatematsu et al., “A polycistronic MicroRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation,” Cancer Research, vol. 65, no. 21, pp. 9628–9632, 2005.
- S. Willimott and S. D. Wagner, “Stromal cells and CD40 ligand (CD154) alter the miRNome and induce miRNA clusters including, miR-125b/miR-99a/let-7c and miR-17-92 in chronic lymphocytic leukaemia,” Leukemia, vol. 26, pp. 1113–1116, 2012.
- K. Conkrite, M. Sundby, S. Mukai et al., “Mir-17~92 cooperates with RB pathway mutations to promote retinoblastoma,” Genes and Development, vol. 25, no. 16, pp. 1734–1745, 2011.
- M. Valladares-Ayerbes, M. Blanco, M. Haz et al., “Prognostic impact of disseminated tumor cells and microRNA-17-92 cluster deregulation in gastrointestinal cancer,” International Journal of Oncology, vol. 39, no. 5, pp. 1253–1264, 2011.
- L. Chen, C. Li, R. Zhang et al., “MiR-17-92 cluster microRNAs confers tumorigenicity in multiple myeloma,” Cancer Letters, vol. 309, no. 1, pp. 62–70, 2011.
- T.-F. F. Chow, M. Mankaruos, A. Scorilas et al., “The miR-17-92 cluster is over expressed in and has an oncogenic effect on renal cell carcinoma,” Journal of Urology, vol. 183, no. 2, pp. 743–751, 2010.
- P. Mu, Y.-C. Han, D. Betel et al., “Genetic dissection of the miR-17-92 cluster of microRNAs in Myc-induced B-cell lymphomas,” Genes and Development, vol. 23, no. 24, pp. 2806–2811, 2009.
- P. A. Northcott, A. Fernandez-L, J. P. Hagan et al., “The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors,” Cancer Research, vol. 69, no. 8, pp. 3249–3255, 2009.
- T. Uziel, F. V. Karginov, S. Xie et al., “The miR-17-92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 8, pp. 2812–2817, 2009.
- S. Nagel, L. Venturini, G. K. Przybylski et al., “Activation of miR-17-92 by NK-like homeodomain proteins suppresses apoptosis via reduction of E2F1 in T-cell acute lymphoblastic leukemia,” Leukemia and Lymphoma, vol. 50, no. 1, pp. 101–108, 2009.
- S. Takakura, N. Mitsutake, M. Nakashima et al., “Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells,” Cancer Science, vol. 99, no. 6, pp. 1147–1154, 2008.
- A. Rinaldi, G. Poretti, I. Kwee et al., “Concomitant MYC and microRNA cluster miR-17-92 (C13orf25) amplification in human mantle cell lymphoma,” Leukemia and Lymphoma, vol. 48, no. 2, pp. 410–412, 2007.
- Y. Liang, D. Ridzon, L. Wong, and C. Chen, “Characterization of microRNA expression profiles in normal human tissues,” BMC Genomics, vol. 8, article 166, 2007.
- D. Bell, A. Berchuck, M. Birrer, et al., “Integrated genomic analyses of ovarian carcinoma,” Nature, vol. 474, no. 7353, pp. 609–615, 2011.
- A. Keller, P. Leidinger, A. Bauer et al., “Toward the blood-borne miRNome of human diseases,” Nature Methods, vol. 8, no. 10, pp. 841–843, 2011.
- V. Olive, M. J. Bennett, J. C. Walker et al., “miR-19 is a key oncogenic component of mir-17-92,” Genes and Development, vol. 23, no. 24, pp. 2839–2849, 2009.
- A. Tsuchida, S. Ohno, W. Wu et al., “miR-92 is a key oncogenic component of the miR-17-92 cluster in colon cancer,” Cancer Science, vol. 102, no. 12, pp. 2264–2271, 2011.
- S. G. Chaulk, G. L. Thede, O. A. Kent et al., “Role of pri-miRNA tertiary structure in miR-17~92 miRNA biogenesis,” RNA Biology, vol. 8, no. 6, 2011.